Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03EBH
|
||||
| Former ID |
DNC004481
|
||||
| Drug Name |
D(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr9-NH2]VT
|
||||
| Indication | Discovery agent | Investigative | [526347] | ||
| Formula |
C52H75N11O13S2
|
||||
| Canonical SMILES |
CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSC2(CCCCC2)CC(=O)NC(C<br />(=O)N1)(C)C3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCN)C(=O)<br />NC(C5=CC=C(C=C5)O)C(=O)N)CC(=O)N)C(C)O
|
||||
| InChI |
1S/C52H75N11O13S2/c1-5-28(2)40-47(73)59-41(29(3)64)48(74)57-35(25-38(54)67)45(71)58-36(27-77-78-52(21-7-6-8-22-52)26-39(68)62-51(4,50(76)61-40)31-15-19-33(66)20-16-31)49(75)63-24-10-12-37(63)46(72)56-34(11-9-23-53)44(70)60-42(43(55)69)30-13-17-32(65)18-14-30/h13-20,28-29,34-37,40-42,64-66H,5-12,21-27,53H2,1-4H3,(H2,54,67)(H2,55,69)(H,56,72)(H,57,74)(H,58,71)(H,59,73)(H,60,70)(H,61,76)(H,62,68)/t28?,29?,34-,35+,36+,37+,40+,41+,42-,51+/m0/s1
|
||||
| InChIKey |
MRGPBAZYRUEDDT-YHXQAOAKSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Vasopressin V1a receptor | Target Info | Inhibitor | [526347] | |
| Oxytocin receptor | Target Info | Inhibitor | [526347] | ||
| Vasopressin V2 receptor | Target Info | Inhibitor | [526347] | ||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| PANTHER Pathway | Oxytocin receptor mediated signaling pathway | ||||
| Pathway Interaction Database | Arf6 trafficking events | ||||
| PathWhiz Pathway | Vasopressin Regulation of Water Homeostasis | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| Peptide GPCRs | |||||
| GPCR ligand binding | |||||
| GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like | |||||
| Myometrial Relaxation and Contraction Pathways | |||||
| Oxytocin signaling | |||||
| Regulation of Water Balance by Renal Aquaporins | |||||
| GPCR downstream signaling | |||||
| References | |||||